Fizy health
Refill supply-duration pricing

Is multi-month supply cheaper on Refill?

Refill does not publish a month-versus-multi-month price table on refill.co. Aggregate pre-negotiated 503A rates for monthly versus multi-month vials are confirmed at demo, and software fees on transactions, published at roughly 1.5–5%, apply on every order regardless of supply duration. A larger vial can lower per-dose drug cost but ties up patient cash flow, changes titration flexibility on GLP-1s, and still carries software fees on the full transaction. Compare on normalized per-dose landed cost, not headline vial price.

This page explains supply-duration traps in Refill pricing and how to compare month versus multi-month economics with software fees included.

Compare Fizy Health vs Refill
Monthly vs multi-month vials Per-dose normalization GLP-1 titration Software fees per order Landed cost comparison Pass-through alternative

Why supply duration changes the economics

Compounded medications ship in vials sized for different supply durations. A multi-month vial may show a lower aggregate per-vial rate than a monthly vial, but per-dose cost is the number that matters for patient programs and clinic margin. On Refill, both durations flow through aggregate pre-negotiated pricing plus software fees on the transaction. Multi-month supply can also conflict with GLP-1 titration schedules if patients move to a higher dose before the vial is finished. The right comparison normalizes drug cost, software fee, and shipping to per-dose or per-week landed cost on the same strength.

How to compare month and multi-month on Refill

Ask Refill for written per-vial cost on both monthly and multi-month options at the same strength. Divide each by doses supplied to get per-dose drug cost. Add software fee percentage on the full transaction value. Add shipping allocated per dose. Compare normalized per-dose landed cost, not the bigger vial's headline price.

For GLP-1 programs, ask whether multi-month vials fit your titration protocol. Patients who titrate up mid-vial may waste supply or need early reorders that reset economics. For TRT and stable-dose hormones, multi-month supply often wins on per-dose cost if rates stay stable across refill cycles. Confirm rate stability in writing, not just the first multi-month quote.

Comparing supply durations with visible per-vial cost

Fizy Health shows resolved per-vial 503A cost on each catalog line before checkout, including different supply durations and strengths, with a disclosed facilitation fee at payment. You can normalize per-dose economics across monthly and multi-month options in the same session without demo quotes for each duration.

Build a side-by-side table: Refill's all-in per-dose cost for monthly versus multi-month at your tier against visible pass-through per-dose cost on the same options. Choose the duration that wins on normalized landed cost and fits your clinical protocol, not the vial size with the best headline aggregate rate.

Optimize vial size on demo quotes — or compare durations in catalog?

Refill fits if

Refill

You will normalize multi-month quotes with software fees at demo.

  • Aggregate multi-month rates beat monthly rates on per-dose math after software fees at your tier.
  • Your protocols support multi-month supply without titration waste on GLP-1s.
  • Meet-or-beat terms and rate stability hold across the supply duration you choose.
Consider Fizy Health if

Fizy Health

You prescribe in-house and compare durations before checkout.

  • You need per-vial cost on monthly and multi-month options visible before the consult.
  • You want to normalize per-dose economics without separate demo quotes per duration.
  • You batch mixed-duration refills in one cart with per-line cost before payment.
If you choose Fizy Health

What you get when every duration shows per-vial cost.

Refill duration economics are confirmed at demo. These outcomes let you compare in catalog.

See all features
Keep evaluating Refill pricing

More on supply-duration economics.

See the full Refill pricing guide
FAQ

What clinics ask about Refill month vs multi-month pricing.

  • Comparison

    Is multi-month supply cheaper on Refill?

    It can be on per-dose drug cost, but Refill does not publish a duration price table. Confirm aggregate rates for both monthly and multi-month vials at demo, add software fees and shipping, and compare normalized per-dose landed cost.

  • GLP-1

    Does multi-month supply work with GLP-1 titration?

    Not always. Patients titrating up may finish a vial early or waste supply. Model economics against your titration protocol, not just per-dose cost on a stable dose.

  • Fees

    Do software fees change with supply duration?

    Software fees are percentage-based on transaction value within published tiers. A larger multi-month order may pay higher absolute software fee dollars even if per-dose drug cost is lower.

  • Method

    How do I normalize month vs multi-month comparison?

    Divide per-vial aggregate rate by doses supplied, add software fee on the transaction, allocate shipping per dose, and compare per-dose landed cost at the same strength.

  • Fizy

    How does Fizy Health show supply-duration pricing?

    Fizy Health shows resolved per-vial 503A cost on each catalog line including different supply durations before checkout, so you can normalize per-dose economics without separate demo quotes.

  • Stability

    Do multi-month rates stay fixed across refill cycles?

    Confirm in writing at demo. Aggregate rates may renegotiate at volume tiers. Multi-month savings assume rate stability over the supply period.

Sources reviewed June 2026

  • Refill public website and published pricing tiers in Refill web app (refill.co), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Compare per-dose cost, not vial headline price.

Normalize monthly and multi-month economics on your top SKUs, then batch one refill day with visible landed cost. Free to start.

Start Ordering Free Fizy Health vs Refill